Julian
Analyst
Stiefel
Equibles does not estimate personal net worth.
About Julian
Julian is recorded as Analyst at Stiefel. Julian has spoken on 1 investor event across 1 company, most recently for Neumora Therapeutics, Inc. on January 5, 2026. The companies whose calls Julian spoke on are classified in the Healthcare sector.
Julian on recent calls
“I guess just, you know, more broadly, really interesting result in the elevated anxiety subgroup. I guess just given, you know, historically, neuropsych trials moving from, you know, early exploratory phase one, phase two studies to phase two, phase three, there's some aggression and effect size.”
Affiliation history
-
Stiefel
Analyst
Transcript header (unverified)
Current